BFRI

BFRI

Biofrontera Inc

Net 40.67%top 1%Rev 11.80%top 1%Net income grew 100% of yearsRevenue grew 100% of years1Y
Hold

Biofrontera Inc. commercializes biopharmaceutical products for dermatological conditions in the U.S. It specializes in photodynamic therapy and offers treatments like Ameluz and RhodoLED lamps for actinic keratosis and other skin issues.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 1 year ago โ†’$1,344today

Score Overview

1 Year
Scoreโ€”
Net Growth40.67%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth11.80%
Rev TrendGrew
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth72.06%
Net Trend75%
Net Income Consistency
Rev Growth73.05%
Rev TrendEvery year
Revenue Consistency

See the full market ranking โ†’

Biofrontera Inc fundamental performance

Across Biofrontera Inc's full reported history, from 2021 to 2025, revenue grew from $ 24M to $ 41M and net income went from -$ 37M to -$ 10M. Revenue increased in 100% of the years measured; net income in 75%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.25โ€”
1 Year2025-08-12
$ 0.9334.41%
All Time2021-10-29
$ 88.20-98.58%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 41M-$ 10M$ 6M
2024$ 37M-$ 17M$ 5M
2023$ 34M-$ 20M$ 1M
2022$ 28M-$ 640K$ 27M
IPO2021$ 24M-$ 37M$ 24M

Explore beyond BFRI

You're looking at Biofrontera Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies